The transcriptional profiling of GLP-1 receptor blockade in EcN-HldSE–treated FDD mice revealed that GLP-1 signaling was essential for maintaining gut barrier integrity and microbial defense pathways during DSS colitis. The gene discussed is GCG; the disease is colitis.